OOIR: Observatory of International Research

Papers

(The H4-Index of Trends in Biotechnology is 54. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)

Article	Citations
Unlocking the potential of stem-cell-derived ‘synthetic’ embryo models	251
Advisory Board and Contents	220
Electronic plants: the future of agriculture and urban ecosystems?	217
(R)evolution-on-a-chip	207
Human Blood–Brain Barrier on a Chip: Featuring Unique Multicellular Cooperation in Pathophysiology	206
Smart Nucleic Acids as Future Therapeutics	166
Subscription and Copyright information	136
Engineering biology approaches to modulate bacterial biofilms	111
Potency Meets Precision in Nano-optimized Chemotherapeutics	109
Designing Artificial Cells towards a New Generation of Biosensors	108
SynMADE: synthetic microbiota across diverse ecosystems	106
Does RNAi-Based Technology Fit within EU Sustainability Goals?	104
Scalable tissue biofabrication via perfusable hollow fiber arrays for cultured meat applications	103
The green revolution of food waste upcycling to produce polyhydroxyalkanoates	102
Microalgae: a revolution for salt-affected soil remediation	97
Phytohormones: novel strategy for removing emerging contaminants and recovering resources	93
Healing wounds with plasma-activated hydrogel therapy	92
Smart materials: rational design in biosystems via artificial intelligence	88
Analyzing and understanding the robustness of bioprocesses	88
Enzyme discovery and engineering for sustainable plastic recycling	87
Manipulating immune activity of macrophages: a materials and mechanics perspective	85
Vibrio natriegens as a host for rapid biotechnology	77
Food Waste: A Promising Source of Sustainable Biohydrogen Fuel	76
Prime editing: advances and therapeutic applications	76
Advisory Board and Contents	74

Advisory Board and Contents	73
Subscription and Copyright information	72
Subscription and Copyright information	72
Towards biomanufacturing of cultured meat	71
Beyond waste: understanding urine’s potential in precision medicine	71
Translational organoid technology – the convergence of chemical, mechanical, and computational biology	71
Multiscale models quantifying yeast physiology: towards a whole-cell model	70
Printhead on a chip: empowering droplet-based bioprinting with microfluidics	70
Manufacturing innovation to drive down cell therapy costs	67
The GPS for drug development: navigating with evidence from human populations	67
Ocular RNA nanomedicine: engineered delivery nanoplatforms in treating eye diseases	65
Mini-bones: miniaturized bone in vitro models	64
Efficient genome-editing tools to engineer the recalcitrant non-model industrial microorganism Zymomonas mobilis	63
Next-generation digital biomarkers: continuous molecular health monitoring using wearable devices	63
A high-performance protein preparation approach in a single column-free step	63
Integrating bicarbonate-based microalgal production with alkaline sewage for ocean negative carbon emissions	61
Machine learning in bioprocess development: from promise to practice	61
Subscription and Copyright information	60
Engineered Living Materials: Taxonomies and Emerging Trends	60
Engineering the mangrove soil microbiome for selection of polyethylene terephthalate-transforming bacterial consortia	60
Emerging supramolecular and living materials in oral medicine	60
Molecular design of microalgae as sustainable cell factories	60
Using synthetic biology to express nitrogenase biosynthesis pathway in rice and to overcome barriers of nitrogenase instability in plant cytosol	57
The LEGO® brick road to open science and biotechnology	57
Multienzymatic synthesis of nylon monomers from vegetable oils	57
The morally disruptive future of reprogenetic enhancement technologies	56
Spatial omics for accelerating plant research and crop improvement	56
Dynamically regulating metabolic fluxes with synthetic metabolons	55
3D printing of heart valves	55
Engineered bacterial therapeutics with material solutions	54
Advisory Board and Contents	54